Healthcare
Live Price
Offline$2.54
+4.96% today
1Y Change
-37.75%
Window
Jun 23, 2025 → Jun 18, 2026
Coverage: 249 bars · Jun 23, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
XTL Biopharmaceuticals Ltd. (XTLB) is a Healthcare stock with a market cap of $10.00M and listed on NASDAQ. The stock last traded around $2.54 and down 37.7% across the available one-year price window (Jun 23, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of 0.0%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS 0.0%, free cash flow -136.5% with operating margin -481.6% and ROIC -29.7%. Valuation already assumes a fairly strong business story at price/sales 19.2. Stock Foundry combines XTLB price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
XTLB
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
XTLB Max Drawdown
-74.88%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for XTLB and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.